Comparative antibacterial activity of a new oral cephalosporin, BMY-28100.

BMY-28100 is a new oral cephalosporin which had in vitro activity superior to that of cephalexin and cefaclor against staphylococci, beta-hemolytic streptococcal species, and Streptococcus pneumoniae. It inhibited beta-lactamase-producing Haemophilus influenzae, Neisseria gonorrhoeae, 50% of Strepto...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Chin, N X, Neu, H C
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174759/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3495236/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.3.480
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!